Merck - Vioxx: the case of the Konstam manuscript

"We had long suspected that this [Circulation] manuscript was ghostwritten, but definitive proof was lacking. These court documents finally confirm our suspicions."

"During the three years after publication of the Konstam manuscript, millions of patients around the world were prescribed rofecoxib by physicians who believed that the drug was safe. In this case, a ghostwritten article caused great harm to the public health."

Read the story.